American Association of Clinical Endocrinologists/American College of Endocrinology Management of Dyslipidemia and Prevention of Cardiovascular Disease Clinical Practice Guidelines-Reference-Cited by-同舟云学术

American Association of Clinical Endocrinologists/American College of Endocrinology Management of Dyslipidemia and Prevention of Cardiovascular Disease Clinical Practice Guidelines

Published:2018-08-01 Issue:3 Volume:31 Page:234-245
ISSN:1040-9165
Container-title:Diabetes Spectrum
language:en
Short-container-title:

Author:

Jellinger Paul S.¹

Affiliation:

1. Center for Diabetes & Endocrine Care, Hollywood, FL, and University of Miami Miller School of Medicine, Miami, FL

Abstract

In Brief In February 2017, the American Association of Clinical Endocrin-ologists and the American College of Endocrinology published updated “Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease.” The update encompassed recent important clinical trial outcomes and additional research related to the treatment of dyslipidemia. This article summarizes key recommendations from this important guideline.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/spectrum/article-pdf/31/3/234/505409/234.pdf

Reference39 articles.

1. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease;Jellinger;Endocr Pract,2017

2. Multi-Ethnic Study of Atherosclerosis: objectives and design;Bild;Am J Epidemiol,2002

3. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA);Blaha;Circulation,2016

4. 10-year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) with validation in the HNR (Heinz Nixdorf Recall) study and the DHS (Dallas Heart Study);McClelland;J Am Coll Cardiol,2015

5. Ezetimibe added to statin therapy after acute coronary syndromes;Cannon;N Engl J Med,2015

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low prevalence of testing for apolipoprotein B and lipoprotein (a) in the real world;American Journal of Preventive Cardiology;2024-09

2. Scoping Review of Nutraceuticals Use in Mediterranean Diet;OBM Integrative and Complementary Medicine;2024-07-05

3. Association of sodium-glucose cotransporter 2 inhibitors with risk of major adverse cardiovascular events in type 2 diabetes patients with acute coronary syndrome: a propensity score‑matched analysis;Cardiovascular Diabetology;2024-03-25

4. A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty Acids;Cardiovascular Drugs and Therapy;2024-02-16

5. A framework for detecting causal effects of risk factors at an individual level based on principles of Mendelian randomization: Applications to modelling individualized effects of lipids on coronary artery disease;2024-01-20